Madrigal Pharmaceuticals, Inc. (MDGL)
540.70
-1.91
(-0.35%)
USD |
NASDAQ |
Sep 04, 16:00
540.70
0.00 (0.00%)
After-Hours: 20:00
Madrigal Pharmaceuticals Cash and Short Term Investments (Annual) : 988.65M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 988.65M |
| December 31, 2024 | 931.25M |
| December 31, 2023 | 634.13M |
| December 31, 2022 | 358.77M |
| December 31, 2021 | 270.35M |
| December 31, 2020 | 284.15M |
| December 31, 2019 | 439.04M |
| December 31, 2018 | 483.72M |
| December 31, 2017 | 191.53M |
| December 31, 2016 | 40.50M |
| December 31, 2015 | 0.3062M |
| December 31, 2014 | 97.69M |
| Date | Value |
|---|---|
| December 31, 2013 | 91.48M |
| December 31, 2012 | 100.60M |
| December 31, 2011 | 39.72M |
| December 31, 2010 | 50.97M |
| December 31, 2009 | 44.16M |
| December 31, 2008 | 73.71M |
| December 31, 2007 | 115.66M |
| December 31, 2006 | 47.36M |
| December 31, 2005 | 62.51M |
| December 31, 2004 | 125.42M |
| December 31, 2003 | 76.23M |
| December 31, 2002 | 28.95M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Exelixis, Inc. | 1.059B |
| Karyopharm Therapeutics, Inc. | 63.74M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Anika Therapeutics, Inc. | 57.48M |